HMG CoA reductase inhibitors (statins) for dialysis patients.
CONCLUSIONS: Statins have little or no beneficial effects on mortality or cardiovascular events and uncertain adverse effects in adults treated with dialysis despite clinically relevant reductions in serum cholesterol levels.
PMID: 24022428 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: Journals (General) Authors: Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF Tags: Cochrane Database Syst Rev Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cholesterol | Databases & Libraries | Dialysis | General Medicine | Heart | Heart Attack | Hemodialysis | Liver | Peritoneal Dialysis | Statin Therapy | Stroke | Study | Toxicology | Urology & Nephrology